Clinical Edge Journal Scan

Excellent prognostic ability of neutrophil-to-lymphocyte ratio in CRC liver metastasis


 

Key clinical point: This meta-analysis demonstrated that the elevated pretreatment neutrophil-to-lymphocyte ratio (NLR) was correlated with poor long-term survival in patients with colorectal cancer (CRC) liver metastasis, including those who underwent surgery.

Major finding: Higher NLR was associated with poor overall survival (OS; hazard ratio [HR] 1.95; P < .01) and disease-free survival (DFS; HR 1.80; P < .01), and normal vs elevated NLR was associated with a better OS among patients who underwent surgery (HR 1.95; P < .01). The 5-year OS and DFS rates were higher in patients with normal vs high NLR (both P < .01).

Study details: The data come from a meta-analysis of 14 retrospective studies including 2974 participants.

Disclosures: This study was supported by the Startup Fund for Scientific Research, Fujian Medical University, China. No conflicts of interest were declared.

Source: Lin N et al. Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: A meta-analysis of results from multivariate analysis. Int J Surg. 2022;107:106959 (Oct 17). Doi: 10.1016/j.ijsu.2022.106959

Recommended Reading

Chronic hepatitis B infections associated with a range of liver malignancies
MDedge Hematology and Oncology
Third COVID booster benefits cancer patients
MDedge Hematology and Oncology
Chronic stress, especially race related, may hasten cancer death
MDedge Hematology and Oncology
How AI is, or will soon be, relevant in radiation oncology
MDedge Hematology and Oncology
Colonoscopy screening leads to modest reduction in risk for CRC
MDedge Hematology and Oncology
Effect of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer
MDedge Hematology and Oncology
Metastatic microsatellite-stable CRC: CXD101 and nivolumab combo shows promise in phase 2
MDedge Hematology and Oncology
Impact of synchronous ovarian metastases on 3-year overall survival in CRC
MDedge Hematology and Oncology
High risk for incident cardiovascular disease in patients with high-risk stage II-III CRC
MDedge Hematology and Oncology
CRC: Severe inflammatory response in early postoperative period increases risk for recurrence
MDedge Hematology and Oncology